Global Anticoccidial Drugs Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the anticoccidial drugs market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Anticoccidial Drugs Market In The Period 2029-2034?

The pharmaceutical stability and storage services market size has experienced robust growth in recent years. This market is expected to expand from $2.66 billion in 2024 to $2.81 billion in 2025, at a compound annual growth rate (CAGR) of 5.8%. The historical growth of this market can be attributed to the escalating demand for biologics, the increasing prevalence of chronic diseases, ongoing advancements in drug development, the rising complexity of drug formulations, and expanding research and development initiatives within the pharmaceutical sector.

The pharmaceutical stability and storage services market is anticipated to experience substantial growth in the upcoming years. It is forecast to expand to $3.57 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.1%. This expansion during the projection period is driven by the increasing prevalence of personalized medicine, growing cold chain logistics, the enlargement of biopharma pipelines, a rise in biologic drug approvals, and the escalating demand for stability testing. Significant developments expected within this forecast period involve technological progress, enhancements in cryogenic storage solutions, advancements in digital monitoring systems, the emergence of innovative packaging methods, and sophisticated temperature-controlled storage facilities.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23473&type=smp

What Strategic Drivers Are Accelerating The Anticoccidial Drugs Market Expansion?

The pharmaceutical stability and storage services market is projected to expand in the future, propelled by the increasing number of novel drug approvals. A novel drug is defined as a pharmaceutical compound that has been newly developed and has not previously received approval for use or marketing. This rise in novel drug approvals is attributable to advancements in biotechnology, which enable the discovery of new compounds, along with improved regulatory processes that facilitate faster and more efficient drug development. The growing number of novel drug approvals consequently boosts demand for pharmaceutical stability and storage services, as these are essential for ensuring optimal conditions, regulatory compliance, and effective shelf-life management. For instance, in October 2023, information from the U.S. Food and Drug Administration (FDA), a U.S.-based federal agency responsible for protecting public health, indicated that in 2022, the FDA approved 37 novel drugs, with 50 further approvals expected in 2024. These approvals are enhancing treatments for various conditions including cancer, rare diseases, neurology, infections, schizophrenia, pain, and Alzheimer’s. Therefore, the increasing number of novel drug approvals is a key driver for the growth of the pharmaceutical stability and storage services market.

What Is The Detailed Segment Distribution Of The Anticoccidial Drugs Market?

The pharmaceutical stability and storage services market covered in this report is segmented –

1) By Service: Stability, Storage

2) By Product Type: Tablets, Capsules, Injectable Solutions, Oral Suspensions, Combination Products, Other Product Types

3) By Molecule: Small Molecule, Large Molecule

4) By Mode: In-House, Outsourcing

5) By End User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Other End Users

Subsegments:

1) Stability Services: Long-Term Stability Studies, Accelerated Stability Studies, Intermediate Stability Studies, Photostability Testing, Forced Degradation Studies

2) Storage Services: Ambient Storage, Refrigerated Storage (2°C to 8°C), Frozen Storage (-20°C to -80°C), Cryogenic Storage (-150°C to -196°C), Controlled Drug Substance And Product Storage

How Are Global Trends Impacting The Development Of The Anticoccidial Drugs Market?

Major companies operating in the pharmaceutical stability and storage services market are prioritizing the development of technologically advanced solutions, such as cryogenic storage suites, to enhance the preservation of pharmaceutical products that are sensitive to temperature. Cryogenic storage suites represent specialized storage facilities engineered to maintain extremely low temperatures, typically below -150°C, to preserve biological and pharmaceutical materials sensitive to temperature, including cell therapies, vaccines, and biologics. For instance, in December 2024, Astoriom, a UK-based stability and biospecimen storage industry firm, unveiled a cryogenic storage suite at its Tramore facility located in County Waterford, Ireland, signifying a major increase in its capabilities for storing biological samples. This cutting-edge suite is designed to meet the growing demand for the safe, long-term preservation of biological materials, ensuring their viability over extended periods. This storage solution offers precise temperature control down to -196°C, vast storage capacity, ISO 9001 certification for regulatory compliance, and advanced security measures, which include access controls and monitoring systems.

Who Are The Major Stakeholders Operating In The Anticoccidial Drugs Market?

Major companies operating in the pharmaceutical stability and storage services market are Cencora Inc, SGS S.A., Eurofins Scientific SE, Catalent Inc, Charles River Laboratories, Intertek Group plc, Element Materials Technology Inc, Alloga UK Ltd., ALS Limited, Pharmaceutical Contract Industries Pharma Services., Almac Group, Alcami Corporation, BioLife Solutions Inc., Auriga Research Private Limited, Reading Scientific Services Ltd., Lucideon Limited, Q Laboratories Inc, PD Partners, Precision Stability Storage, Roylance Stability Storage Limited

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-stability-and-storage-services-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Anticoccidial Drugs Market?

North America was the largest region in the pharmaceutical stability and storage services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical stability and storage services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=23473&type=smp

Browse Through More Reports Similar to the Global Anticoccidial Drugs Market 2025, By The Business Research Company

Storage And Warehouse Leasing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/storage-and-warehouse-leasing-global-market-report

Oil Storage Market 2025

https://www.thebusinessresearchcompany.com/report/oil-storage-market

External Storage Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/external-storage-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795